Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia

Not Applicable

• Conditions: Pre-Eclampsia
• Interventions: Diagnostic Test: Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP

• Registration Number: NCT03630276
• Lead Sponsor: Ain Shams University

Brief Summary

Evaluation of neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP as markers of severity of Pre-eclampsia

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-08
• Study Start: 2018-08-01
• Primary Completion: 2018-08-10
• Study Completion: 2018-08-10
• Study First Submitted: 2018-08-10
• Study First Submitted QC: 2018-08-10
• Last Update Submitted: 2018-08-10
• Study First Posted: 2018-08-14
• Last Update Posted: 2018-08-14

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 111

Inclusion Criteria

• PREECLAMPSIA from 25_45years

Read More

Exclusion Criteria

• chronic diseases Primary hypertension

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Neutrophil/lymphocyte ratio	Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP	-
Platelet/lymphocyte ratio	Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP	-
CRP	Neutrophil/lymphocyte ratio, Platelet /lymphocyte ratio and CRP	-

Primary Outcome Measures

Name	Time	Method
PREECLAMPSIA	6months

Trial Locations

Locations (1)

Shaza; 🇪🇬 Alexandria, Alex, Egypt